Product Type: | Mouse monoclonal IgG2b, primary antibodies |
---|---|
Species reactivity: | Human, Mouse, Rat |
Applications: | WB, IF-Cell, FC |
Clonality: | Monoclonal |
Clone number: | A8E4 |
Form: | Liquid |
Storage condition: | Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles. |
Storage buffer: | PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide. |
Concentration: | 1ug/ul |
Purification: | Protein A affinity purified. |
Molecular weight: | Predicted band size: 22 kDa |
Isotype: | IgG2b |
Immunogen: | Recombinant protein within human KRAS aa 2-186. |
Positive control: | HeLa cell lysate, A549 cell lysate, Jurkat cell lysate, PC-12 cell lysate, Mouse brain tissue lysate, Rat brain tissue lysate, Hela, NIH/3T3. |
Subcellular location: | Cell membrane. Cytoplasm. |
Recommended Dilutions:
WB IF-Cell FC |
1:1,000 1:200 1:500-1:1,000 |
Uniprot #: | SwissProt: P01116 Human | P32883 Mouse | P08644 Rat |
Alternative names: | c Ki ras2 c Kirsten ras protein c-K-ras c-Ki-ras Cellular c Ki ras2 proto oncogene Cellular transforming proto oncogene CFC2 cK Ras GTPase KRas K RAS p21 protein K RAS2A K RAS2B K RAS4A K RAS4B K-Ras 2 KI RAS Ki-Ras KIRSTEN MURINE SARCOMA VIRUS 2 Kirsten rat sarcoma 2 viral (v Ki ras2) oncogene homolog Kirsten rat sarcoma viral oncogene homolog KRAS KRAS proto oncogene, GTPase KRAS1 KRAS2 N-terminally processed NS NS3 Oncogene KRAS2 p21ras PR310 c K ras oncogene PR310 cK ras oncogene RALD RASK_HUMAN RASK2 Transforming protein p21 v Ki ras2 Kirsten rat sarcoma 2 viral oncogene homolog v Ki ras2 Kirsten rat sarcoma viral oncogene homolog |
Fig1:
Western blot analysis of KRAS on different lysates with Mouse anti-KRAS antibody (HA601058) at 1/1,000 dilution. Lane 1: HeLa cell lysate (20 µg/Lane) Lane 2: A549 cell lysate (20 µg/Lane) Lane 3: Jurkat cell lysate (20 µg/Lane) Lane 4: PC-12 cell lysate (20 µg/Lane) Lane 5: Mouse brain tissue lysate (40 µg/Lane) Lane 6: Rat brain tissue lysate (40 µg/Lane) Predicted band size: 22 kDa Observed band size: 22 kDa Exposure time: 2 minutes; ECL: K1801; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601058) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. |
|
Fig2:
Immunocytochemistry analysis of Hela cells labeling KRAS with Mouse anti-KRAS antibody (HA601058) at 1/200 dilution. Cells were fixed in 4% paraformaldehyde for 30 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes, and then blocked with 2% BSA for 30 minutes at room temperature. Cells were then incubated with Mouse anti-KRAS antibody (HA601058) at 1/200 dilution in 2% BSA overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. |
|
Fig3:
Flow cytometric analysis of NIH/3T3 cells labeling KRAS. Cells were fixed and permeabilized, and then blocked with 2% negative goat serum for 15 minutes at room temperature.Then stained with the primary antibody (HA601058, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). |